- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Di | Aura Biosciences, Inc.: Aura Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights | 223 | Phase 3 CoMpass trial fully enrolled with 108 patients, exceeding enrollment target; on track for topline data in 2H 2027 Strategic operating plan refined to focus on development of bel-sar in ocular... ► Artikel lesen | ||
| Di | Beamr Imaging Ltd.: Beamr Issues Q2-2026 CEO Letter to Shareholders: Expanding Our Reach into Autonomous Vehicle Teams | 557 | Herzliya, Israel, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today issued a Letter to Shareholders from Sharon Carmel... ► Artikel lesen | ||
| Di | CalciMedica, Inc.: CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates | 569 | Completed private placement financing of up to approximately $49 million to advance pulmonary hypertension program Auxora Phase 1b proof-of-concept data in pulmonary arterial hypertension (PAH) and... ► Artikel lesen | ||
| Di | Prelude Therapeutics, Incorporated: Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | 218 | The Company expects to initiate its Phase 1 study of PRT13722, a first-in-class highly-selective oral KAT6A degrader in HR+ breast cancer in the fourth quarter Presented preclinical data demonstrating... ► Artikel lesen | ||
| Di | BRAZIL POTASH CORP: Brazil's Court of Appeal Perserves Rulings Favourable to the Autazes Potash Project, Blocks Referral of Appeals to Superior Courts | 194 | Appeals court reaffirms the Mura consultation process was properly conducted, the Amazon State Environmental agency's (IPAAM) licensing authority, and the validity of the Autazes Project's environmental... ► Artikel lesen | ||
| Di | Beyond Meat, Inc.: Beyond Meat Announces 1-for-30 Reverse Stock Split | 434 | EL SEGUNDO, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (the "Company") today announced that its board of directors (the "Board") has selected a 1-for-30 reverse stock... ► Artikel lesen | ||
| Di | Gain Therapeutics, Inc.: Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update | 274 | BETHESDA, Md., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of... ► Artikel lesen | ||
| Di | Tango Therapeutics, Inc.: Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights | 165 | Company continues to prepare for late-stage clinical advancement of vopimetostat in combination with daraxonrasib for pancreatic cancer following positive Phase 1/2 data Phase 1/2 data from combination... ► Artikel lesen | ||
| Di | Aldebaran Resources Inc.: Aldebaran Resources and Centauri Minerals Announce Shareholder Approval and Receipt of Final Order for Spin-Out of Centauri Minerals | 143 | VANCOUVER, British Columbia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Aldebaran Resources Inc. ("Aldebaran") (TSX-V: ALDE, OTCQX: ADBRF) and its majority-owned subsidiary Centauri Minerals Inc. ("Centauri"... ► Artikel lesen | ||
| Di | AC Immune SA: AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson's Disease (PD) | 548 | AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson's Disease (PD) Ongoing Phase 2 VacSYn study to expand to sites in USA... ► Artikel lesen | ||
| Di | Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update | 189 | ~ 2026 Second Quarter Net Product Sales of $17.1 Million, Up 78% Year over Year ~ ~ 2026 Second Quarter Non-GAAP Adjusted EBITDA of $2.8 Million ~ ~ Record PEDMARK- Demand Carried into Third Quarter... ► Artikel lesen | ||
| Di | Elicera Therapeutics AB: Elicera Therapeutics: Last patient treated in the Phase I part of the CARMA study - tumor responses in 10 of 11 patients evaluated to date | 158 | Gothenburg, August 11, 2026 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next generation cancer treatments based on oncolytic viruses and CAR T-cell therapies... ► Artikel lesen | ||
| Di | The Descartes Systems Group Inc: ArrowXL Reduces Fleet Mileage in Home Delivery Operations by 13% with Descartes | 682 | LONDON and ATLANTA, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that ArrowXL... ► Artikel lesen | ||
| Di | Lithium Argentina AG: Lithium Argentina Reports Second Quarter 2026 Results | 264 | ZUG, Switzerland, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Lithium Argentina AG ("Lithium Argentina" or the "Company") (TSX: LAR) (NYSE: LAR) today announced its second quarter 2026 results. Unless otherwise... ► Artikel lesen | ||
| Di | Orezone Gold Corporation: Orezone Reports Positive Drill Results at Bomboré Demonstrating Growth Potential Ahead of Mineral Resource and Reserve Update in Q1 2027 | 647 | VANCOUVER, British Columbia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE | ASX: ORE | OTCQX: ORZCF) (the "Company" or "Orezone") is pleased to provide additional drill results... ► Artikel lesen | ||
| Di | Pet Valu Holdings Ltd.: Pet Valu Reports Second Quarter 2026 Results | 423 | Grows Revenue 4%, Adjusted EBITDA(1) 8% and Net Income 14%Reaffirms 2026 Outlook MARKHAM, Ontario, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pet Valu Holdings Ltd. ("Pet Valu" or the "Company") (TSX: PET)... ► Artikel lesen | ||
| Di | Vireo Growth Inc. Announces Second Quarter 2026 Results | 1.023 | Q2 GAAP revenue of $209.3 million increased 335% year-over-year, driven by recently closed M&A transactions. Q2 proforma revenue of $254.9 million, gives effect to the acquisitions of Hawthorne, Bridgewell... ► Artikel lesen | ||
| Di | Parsons Corporation: Parsons Awarded $40 Million Electronic Warfare National Security Contract | 636 | Key Takeaways: Parsons was awarded a $40 million non-kinetic effects contract to advance next-generation electromagnetic warfare capabilities for U.S. Army national security missions.Parsons' expertise... ► Artikel lesen | ||
| Di | Cineplex Inc.: Cineplex Reports Record Second Quarter 2026 Revenues With 20.4% Growth in Adjusted EBITDAaL | 449 | TORONTO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Today, Cineplex Inc. ("Cineplex" or the "Company") released its financial results for the three and six months ended June 30, 2026. Unless otherwise specified... ► Artikel lesen | ||
| Di | Northland Power Inc.: Northland Power Optimises Debt Financing at Hai Long Offshore Wind Project and Increases Project's Debt Funding by $0.9 Billion | 614 | Financing Highlights
$2.4 billion of new Taiwan dollar-denominated debt facilities at the 100% project interest level, including $0.9 billion of incremental funding through project completionOptimizes... ► Artikel lesen | ||
| Di | Goliath Resources Limited: Goliath Intercepts Up To 10.32 g/t Au Over 6.00 Meters Within The New 320 Meter Expansion Area Of Golden Gate Zone To The Northeast, Remains Open, On High-Grade Gold Surebet Discovery, Golden Triangle, B.C. | 9.615 | Gold assay results have been intercepted in additional drill holes demonstrating continuity and predictability of the new 320 meter expansion area of the Golden Gate Zone to the Northeast (see news... ► Artikel lesen | ||
| Di | Comstock Inc.: Comstock Metals Brings Fully Integrated Industry-Scale Solar Recycling System Online | 758 | SILVER SPRINGS, Nev., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company") and Comstock Metals LLC ("Comstock Metals"), a leader in the responsible, zero-landfill... ► Artikel lesen | ||
| Di | Shattuck Labs, Inc.: Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights | 334 | - Phase 1 clinical trial results for SL-325 demonstrated a favorable safety profile, a potentially best-in-mechanism immunogenicity profile, and durable DR3 blockade of TL1A binding, potentially enabling... ► Artikel lesen | ||
| Di | Altus Group Limited: Altus Group Releases its Q2 2026 Pan-European Dataset Analysis on CRE Valuation Trends | 419 | Q2 marked two full years of positive appreciation in property values, but momentum eases
Property value increases eased to 0.3% in Q2 2026 as office values leveled off
LONDON, Aug. 11, 2026... ► Artikel lesen | ||
| Di | Zymeworks Inc.: Zymeworks Announces Participation in Upcoming Investor Conferences | 205 | VANCOUVER, British Columbia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.